Global Cathodic Protection Market Set to Soar at an Impressive 5.2% CAGR, Predicted to Reach US$ 7.64 Billion by 2033

The Cathodic Protection Market report, unveiled by Future Market Insights—an ESOMAR Certified Market Research and Consulting Firm—presents invaluable insights and meticulous analysis of the Cathodic Protection market. Encompassing the research’s scope and essence, this report scrupulously examines the driving factors, market size, and predictive data for Cathodic Protection. It furnishes intricate revenue and shipment segmentations, accompanied by a decade-long projection up to 2033. Additionally, the document evaluates key industry players, their market distribution, the competitive scenario, and regional perspectives.

The cathodic protection market is poised for an extraordinary surge, with a projected Compound Annual Growth Rate (CAGR) of 5.2% between 2023 and 2033. By 2033, this dynamic market segment is anticipated to hold an impressive market share of US$ 7.64 billion, compared to the expected value of US$ 4.60 billion in 2023.

Gain Valuable Insights: Evaluate Market Potential with Our Detailed Market Overview – Request a Sample Now
https://www.futuremarketinsights.com/reports/sample/rep-gb-6526

Driving Factors Accelerating Market Growth:

  1. Infrastructure Development Surge: The global infrastructure development wave is driving the cathodic protection market to new heights. As nations invest heavily in critical infrastructure projects, corrosion protection becomes paramount, boosting the demand for cathodic protection systems across various sectors.
  2. Energy Sector Expansion: The relentless growth of the energy sector, particularly in oil and gas, underscores the need for cathodic protection to safeguard vital assets. Pipelines, tanks, and offshore structures require reliable corrosion prevention, thus bolstering market growth.
  3. Stringent Regulatory Compliance: Governments worldwide are enforcing strict regulations to ensure the safety and longevity of infrastructure. Adherence to these regulations necessitates the implementation of cathodic protection systems, further propelling market expansion.
  4. Technological Advancements: Continuous innovations in cathodic protection technologies are offering more efficient and cost-effective solutions. These advancements attract businesses seeking superior corrosion prevention, enhancing the market’s allure.

Challenges Restraining Market Progress:

  1. High Initial Investment: The upfront cost of installing cathodic protection systems can be substantial, deterring smaller enterprises from investing in comprehensive corrosion prevention measures.
  2. Complex Maintenance: Maintaining cathodic protection systems demands expertise and resources, posing a challenge for some organizations. This complexity can hinder market growth in certain regions.
  3. Environmental Concerns: The use of certain cathodic protection materials and methods may raise environmental concerns. Stricter environmental regulations could potentially limit market expansion.

Key Takeaways:

  • Industrial Production Index (IPI) Significance: The IPI is a crucial metric that gauges the output of manufacturing, mining, electric, and related industries, all of which play pivotal roles in the market’s downstream segments.
  • Corrosion Protection Demand: Increasing output in these key industries is driving a surge in demand for corrosion protection services. This demand extends to both preserving existing infrastructure and enhancing the durability of new construction, especially in processing plants.
  • Promising Forecast: The IPI is poised to experience substantial growth in the foreseeable future. This growth is expected to translate into a plethora of opportunities for manufacturers operating in the cathodic protection market.
  • Business Opportunity: Manufacturers should keenly monitor the rising IPI as it signifies a potential avenue for expansion and profitability within the cathodic protection market. Meeting the corrosion protection needs of these booming industrial sectors is essential for market success.

Elevate Your Progress: Tailored Strategies for Advancing in the Cathodic Protection Market https://www.futuremarketinsights.com/customization-available/rep-gb-6526

Competitive Landscape:

Cathodic protection suppliers are actively engaged in the development of innovative solutions to cater to the evolving global infrastructure landscape. Several industry players are also strategically expanding their distribution networks across diverse geographical regions and industry sectors.

As an illustrative example, in March 2022, Savcor Products Australia introduced a pioneering product—a compact and advanced line of galvanic anodes designed specifically for concrete structures. These alkali-activated anodes are characterized by their ease of installation, suitability for embedding beneath the concrete cover, and a zinc content of 130 grams. Furthermore, they excel in terms of current distribution and provide long-term protection for the surrounding repair area. This initiative exemplifies the commitment of industry players to staying at the forefront of technological advancements and enhancing their competitive edge in the market.

Key Players:

  • Aegion Corporation
  • BAC Corrosion Control Ltd
  • Cathodic Protection Co Ltd
  • CMP Europe
  • Farwest Corrosion Control Compan
  • Imenco AS
  • James Fisher
  • MATCOR, Inc
  • Nakabohtec Corrosion Protecting Co
  • The Nippon Corrosion Engineering Co

For a Seamless Purchase Experience, Contact our Sales Team for Assistance: https://www.futuremarketinsights.com/checkout/6526

Key Segments Covered

By Solution:

  • Products
  • Anodes
  • Power Supplies
  • Junction Boxes
  • Test Stations
  • Remote Monitors
  • Coating
  • Instrumentation
  • Others
  • Services
  • Inspection
  • Design & Construction
  • Maintenance

By Type:

  • Galvanic (Sacrificial Anodes)
  • Impressed Current

By Application:

  • Pipelines
  • Storage Facilities
  • Processing Plants
  • Water & Wastewater
  • Transportation
  • Bridges
  • Airports
  • Fuelling Systems
  • Metros
  • Building
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Compost Turning Machine Market Forecast: Rising at a 3.8% CAGR between 2023 and 2033, Reaching US$ 181.2 Million

Future Market Insights (FMI), an esteemed provider of market intelligence and consulting services certified by ESCOMAR, unveils a profound analysis of the global compost turning machine market. The market, valued at an anticipated US$ 120.3 million in 2022, is poised for sustained growth driven by a surge in demand for compost-turning machines across diverse industries. The burgeoning adoption of these machines in agriculture, construction, and manufacturing industries is a key factor propelling growth, with the market projected to attain US$ 181.2 million by 2033, recording a robust Compound Annual Growth Rate (CAGR) of 3.8% between 2023 and 2033.

Turning Organic Practices into Growth Opportunities

The worldwide trend toward embracing organic farming methods has significantly influenced the demand for compost turning machines. These machines assume a critical role in the efficient conversion of organic waste into valuable resources for agricultural applications. Concurrently, the swift progress of industrialization and urban development is driving the need for compost-turning machinery, in alignment with sustainable waste management principles.

Moreover, the escalating emphasis on wastewater treatment initiatives is acting as a catalyst for market expansion. Compost turning machines play a vital role in the efficient treatment and recycling of organic waste, thereby contributing significantly to the advancement of environmental sustainability.

Gain a comprehensive understanding of the market landscape and unlock growth opportunities. Request a sample today to explore our detailed market overview
https://www.futuremarketinsights.com/reports/sample/rep-gb-4061

Addressing the Climate Emergency through Innovative Solutions
In the midst of a critical climate emergency, waste management has risen to the forefront as a paramount concern. Governments worldwide are proactively implementing rigorous regulations and measures to ensure the efficient handling of waste. This evolving landscape is expected to have a substantial impact on the demand for compost milling machines, compost turner machines, and associated solutions that play a pivotal role in waste reduction and the optimization of valuable resources.

Navigating Market Dynamics: Opportunities and Challenges

Manufacturers in the compost-turning system sector are actively allocating resources to advance their research and development efforts, with a primary focus on improving the efficiency and efficacy of their machinery. These initiatives are driven by the goal of providing more sustainable and impactful waste management solutions that can adapt to the evolving demands of consumers.

In this quest for innovation, Reencle gained notable recognition in October 2021 due to its groundbreaking food recycler. This innovative device boasts the remarkable capability to compost food waste in a mere 24-hour timeframe. Notably, its compact form factor significantly contributed to its widespread appeal, evidenced by the sale of over 49,000 units. This success underscores the growing demand for smaller compost turners and related machinery in the market.

BDP Industries, a distinguished player in the industry, has earned acclaim for its pioneering dewatering and composting equipment solutions. Their comprehensive product range and accompanying services cater to a diverse array of industries. In doing so, BDP Industries is making a significant contribution to the overarching sustainability agenda in the realm of waste management.

Regional Insights: Cultivating Growth Across Borders

North America is poised to assume a pivotal position in the compost turning machine market, primarily attributed to its robust commitment to sustainable waste management practices. The region is anticipated to secure a significant portion of the global market revenue, propelled by a convergence of factors including proactive government initiatives, stringent regulatory frameworks, and an escalating consciousness of environmental imperatives.

In this era marked by escalating sustainability concerns, the global compost turning machine market continues to flourish. Future Market Insights remains unwavering in its dedication to delivering profound analysis and illuminating industry trends, thereby equipping stakeholders with invaluable strategic perspectives.

Competitive Landscape: Innovating for Efficiency and Expanding Global Footprint

Pioneering Research and Development for Enhanced Efficiency
Manufacturers specializing in compost-turning systems have positioned themselves at the vanguard of innovation. They are directing their energies towards pioneering research and development initiatives aimed at enhancing the operational capabilities of compost machines. Through the integration of cutting-edge technologies, these manufacturers exhibit a steadfast commitment to improving the effectiveness and efficiency of composting equipment, in alignment with the ever-evolving demands of the industry and its sustainability objectives.

Looking to Purchase this Report? Contact Sales for Dedicated Support https://www.futuremarketinsights.com/checkout/4061

Global Reach: Strengthening Market Presence
Compost-turning equipment suppliers are executing strategic expansion initiatives to enhance their market presence in diverse regions. This strategic approach is designed to capitalize on a wide range of market prospects and cater to the unique requirements of various geographical areas. Through the establishment of strong market positions in multiple regions, these suppliers are well-positioned to efficiently meet the global demand for composting solutions.

Key Players:

  • Terex Corporation (Ecotec)
  • Vermeer Corporation
  • Eggersmann Anlagenbau GmbH
  • SCARAB International
  • Midwest Bio-Systems Inc.
  • Brown Bear Corporation
  • ALLU Finland Oy
  • EYS Metal San. ve Tic. Ltd. Sti.
  • EZ Machinery,
  • Komptech Group

Key Segments of Compost Turning Machine Industry Survey

Compost Turning Machine Market by Product Type:

  • Drum Compost Turning Machines
  • Elevating Face Compost Turning Machines

Compost Turning Machine Market by Output Capacity:

  • Below 500 Cubic Mtrs/h
  • Between 500-1,000 Cubic Mtrs/h
  • More than 1,000 Cubic Mtrs/h

Compost Turning Machine Market by End Use:

  • Compost Turning Machines for Construction Industry
  • Compost Turning Machines for Agriculture Industry
  • Compost Turning Machines for Manufacturing Industry

Compost Turning Machine Market by Region:

  • North America Compost Turning Machine Market
  • Latin America Compost Turning Machine Market
  • Western Europe Compost Turning Machine Market
  • Eastern Europe Compost Turning Machine Market
  • East Asia Compost Turning Machine Market
  • South Asia & Pacific Compost Turning Machine Market
  • Middle East & Africa (MEA) Compost Turning Machine Market

Charting a Path to Success: Personalized Knowledge for Compost Turning Machine Market Expansion
https://www.futuremarketinsights.com/customization-available/rep-gb-4061

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com

Global Endoscopic Ultrasound Needles Industry Expected to Reach US$ 223.5 Million with 4.4% CAGR by 2027 | FMI Insights

Global Endoscopic Ultrasound Needles Industry
Global Endoscopic Ultrasound Needles Industry

Future Market Insights (FMI) has unveiled promising growth prospects for the Global Endoscopic Ultrasound Needles Industry. The market, valued at US$180.2 million in 2022, is projected to reach US$223.5 million by 2027, reflecting a steady growth trajectory over the next three years.

Endoscopic ultrasound needles are becoming increasingly vital in the medical field, offering minimally invasive procedures and innovative products for fine needle aspiration (FNA) and fine needle biopsy (FNB) for solid lesions. This progress underscores their widespread acceptance among surgeons and healthcare professionals as a safe and effective method, contributing significantly to the growth of the Global Endoscopic Ultrasound needle industry.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-9247

Manufacturers in the Global Endoscopic Ultrasound Needles Industry are focusing on new product launches for more precise diagnosis of tissues collected using needles. Gaining a greater share in the endoscopic ultrasound needles market with a diverse portfolio is one of the key strategies of leading players.

As per the report, companies in the Global Endoscopic Ultrasound needle industry are also focusing on collaborating for the development and distribution of advanced endoscopic ultrasound needle products. Key players in the endoscopic ultrasound needles market are focusing on new product development in emerging regions including Latin America and Asia Pacific owing to the increasing prevalence of cancer and other chronic diseases. Endoscopic Ultrasound-Guided Fine Needle Aspiration to Gain Popularity with Rise in Gastrointestinal Diseases

According to the FMI report, Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) is likely to account for the largest share of the endoscopic ultrasound needles market. EUS-FNA gaining popularity for the diagnosis of gastrointestinal diseases and peri-gastrointestinal lesions. The wide application of FNA has also accelerated the growth in the endoscopic ultrasound needles market.

With the growing demand for minimally invasive procedures, doctors and surgeons are using EUS combined with FNA to collect sample fluid and tissue from the chest and abdomen for diagnosis. It has also emerged as an alternative to exploratory procedure.

Discovering the assumptions behind the study. Ask from Market Research Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-9247

Meanwhile, in recent years studies conducted on Endoscopic Ultrasound-Guided Fine Needle Biopsy (EUS-FNB) have shown some promising results. As per the FMI study on the endoscopic ultrasound needles market, FNB is emerging as a novel tool in diagnosis by providing information on tissue architecture.

As per the study, ambulatory surgical centers will use endoscopic ultrasound needles on a large scale owing to the rise in the number of these centers and the increasing number of endoscopic ultrasound surgeries performed in ambulatory surgical centers. Being the minimally invasive and non-surgical procedure that can be performed through the colon or upper GI tract, ambulatory surgical centers are gaining traction in the Global Endoscopic Ultrasound needle industry.

Moreover, endoscopic ultrasound is generally considered safe when performed at ambulatory surgical centers with expert healthcare teams. Various healthcare organizations are building ambulatory surgical centers within the premises of the healthcare facility offering a wide range of services with technological advancements to achieve economies of scale.

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-9247

An increasing number of ambulatory surgical centers are offering safe, cost-effective services, especially for gastroenterology, thereby, driving the demand in the Global Endoscopic Ultrasound Needles Industry.

Endoscopic Ultrasound Needles Industry Survey

Global Endoscopic Ultrasound Needles Industry by Product:

Global Endoscopic Ultrasound Needles Industry by Application:

  • Bronchial EUS Needles
  • Enteral EUS Needles

Global Endoscopic Ultrasound Needles Industry by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Global Endoscopic Ultrasound Needles Industry by Region:

  • North America Endoscopic Ultrasound Needles Market
  • Latin America Endoscopic Ultrasound Needles Market
  • Europe Endoscopic Ultrasound Needles Market
  • East Asia Endoscopic Ultrasound Needles Market
  • South Asia & Pacific Endoscopic Ultrasound Needles Market
  • Middle East & Africa (MEA) Endoscopic Ultrasound Needles Market

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/9247

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Allergy Immunotherapy Industry is expected to surpass US$ 4.07 Billion, growing at a rate of 8.9% CAGR By 2033 | FMI

Global Allergy Immunotherapy Industry
Global Allergy Immunotherapy Industry

The Global Allergy Immunotherapy Industry is poised for significant growth, according to a recent market analysis by Future Market Insights (FMI). The market, valued at an estimated US$1.74 billion in 2023, is projected to experience a remarkable Compound Annual Growth Rate (CAGR) of 8.9% over the next decade. By 2033, the market is expected to surpass an impressive milestone, reaching a valuation of US$4.07 billion.

The burgeoning allergy immunotherapy industry is carving its path to success by adopting principles similar to those utilized in immunotherapy treatments for cancer. While the spotlight often shines on cancer immunotherapy for its innovative approaches, it is essential to acknowledge the growing significance of allergy immunotherapy in addressing allergies, which impact millions of individuals worldwide.

This substantial growth trajectory highlights the market’s potential for substantial advancements in allergy treatment, significantly improving the lives of those suffering from allergies. It also underlines the market’s commitment to harnessing the principles of immunotherapy for the greater good, showcasing innovation that extends beyond the realm of cancer treatment.

Request a Sample Report Now to get Premium Insights:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9043

The predicted revenue growth could be related to the burden of allergy conditions, which are becoming more prevalent globally. The responsibility that complex allergies with increased morbidity place on the healthcare system motivates research and development in this area for the introduction of innovative medicines.

The primary factors propelling the global market are:

  • The expansion of industrialization and population.
  • Improvements in healthcare and medicine.
  • The launch of novel immunotherapeutic medications.

Current regulatory approvals, such as those for oral dissolvable tablets, are further enhanced to gain a larger global allergy immunotherapy industry share.

Compared to other treatments already on the market, sublingual allergy immunotherapy has been clinically shown to be more effective and have fewer adverse effects. Another factor influencing the allergy immunotherapy industry growth is the demographic shift in the population and the macroeconomic environment.

The prevalence of asthma and allergy respiratory illnesses has increased due to rising air pollution levels inside and outside. According to the Asthma and Allergy Association of America (AAFA), rising pollen levels cause more than 25 million allergies.

Europe and North America are the two leading markets for allergy immunotherapy, and they are likely to continue holding a sizable market share during the forecast period. Given the increased awareness, healthcare reimbursement regulations, and growth in the population who suffer from allergies, Europe is estimated to hold a significant portion of the global allergy immunotherapy industry.

Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-9043

“Allergy immunotherapy represents a transformative approach to allergy treatment. This therapeutic method offers long-term relief by desensitizing the immune system to allergens, fundamentally changing how we manage allergies and providing hope for sufferers worldwide.”—by Lead Analyst at Future Market Insights.

Global Allergy Immunotherapy Industry KEY TAKEAWAYS:

  • The market in the United Kingdom is anticipated to rise, exhibiting a CAGR of 9.1% through 2033.
  • The United States is expected to develop at a 9.1% CAGR during the forecast period.
  • With a CAGR of 9.3% over the forecast period, Canada is predicted to grow rapidly in the market.
  • The market in China is expected to increase, registering a CAGR of 8.8% over the forecast period.
  • Germany is estimated to grow decently, registering a CAGR of 9.7% until 2033.

Global Allergy Immunotherapy Industry COMPETITIVE LANDSCAPE:

Top players operating in the allergy immunotherapy market are ALK Abello, Stallergenes Greer, Allergy Therapeutics, Aimmune Therapeutics, Anergis, Arrayit Corporation, Biomay AG, HAL Allergy Group, DBV Technologies, and others.

These key players in the market are developing innovative products, such as sublingual and subcutaneous immunotherapy, to cater to the growing demand for effective allergy treatments. They also invest in research and development to improve existing therapies’ efficacy and safety and expand their market reach through strategic partnerships and collaborations.

Recent Developments from the Global Allergy Immunotherapy Industry:

  • In September 2021, ALK confirmed that by expanding the number of patients by at least 100,000 yearly, it intends to make allergy testing, immunotherapy treatments, and adrenaline products accessible by 2030.
  • In June 2021, with the complete restoration of SCIT manufacturing in Antony, Stallergenes Greer declared that Alustal®, its subcutaneous allergen immunotherapy (SCIT) remedy, is now accessible in Italy and Spain.

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/9043

Global Allergy Immunotherapy Industry Segmentation:

By Product:

  • SLIT Tablets
    • Odactra
    • Grastek
    • Ragwitek
    • Oralair
    • Actair
    • Others
  • Oral
    • Palforzia
    • Others
  • Injections
  • Others

By Immunotherapy:

  • Sublingual Immunotherapy
  • Subcutaneous Immunotherapy
    • Specific Immunotherapy
  • Others

By Indication:

By Allergen:

  • Pollens
    • Grass Pollens
    • Weed Pollens
    • Tree Pollens
  • House Dust Mites
  • Mold
  • Animal Dander
  • Bee Venom
  • Cockroaches/Insects
  • Others

By Distribution Channel:

  • Institutional Sales
    • Government Hospitals
    • Semi-Government Hospitals
    • Private Hospitals
  • Retail Sales
    • Retail Pharmacy
    • Drug Stores
    • Online Pharmacy

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry reaching a projected valuation of US$47.05 Billion, at a steady CAGR of 3.6

Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry
Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry

The Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry is poised for significant growth in the coming decade, according to a recent market analysis. Valued at US$33.03 billion in 2024, the market is expected to ascend at a steady Compound Annual Growth Rate (CAGR) of 3.6% from 2024 to 2034, reaching a projected valuation of US$47.05 billion by the end of the forecast period.

One of the key drivers of this remarkable growth is the increasing preference for minimally invasive surgical procedures. Patients and healthcare professionals alike are recognizing the benefits of these approaches, leading to a surge in demand for benign prostatic hyperplasia (BPH) prostate treatment options.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-1664

The increasing cases of benign prostatic hyperplasia (BPH) along with a surge in preference for minimally invasive surgeries are primary growth drivers of the target market. Furthermore, the growing popularity of Ayurveda, especially in South Asian countries, will generate more growth-inducing opportunities for the BPH treatment market. Due to all of these considerations, the target market observed a surge in growth rate as it rose to a CAGR of 3.7% from 2013 to 2021.

Heightened emphasis on healthcare, a growing geriatric population, degenerating lifestyle, poor dietary habits, hereditary inheritance of the disease, advancing research and development, and better availability of treatment procedures are some of the prominent factors that positively influence the BPH treatment market growth during the forecast period.

“Rising adoption of minimally invasive procedures coupled with rising incidences of benign prostatic hyperplasia will augment the global growth of the benign prostatic hyperplasia (BPH) prostate treatment market over the forecast period,” says an FMI analyst.

Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry Key Takeaways:

  • The BPH treatment market is expected to witness consistent growth due to a rising aging population and increasing prevalence of BPH.
  • Growing awareness of BPH and minimally invasive treatment options are expected to drive market expansion.
  • Technological advancements in BPH treatment procedures, including minimally invasive surgeries and laser therapies, are a key driver of market growth.
  • Increasing healthcare expenditure in developed and developing countries is expected to further fuel market expansion.

Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1664

Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry Competitive Landscape

Pfizer Inc., NxThera Inc., NeoTract Inc., Sanofi S.A, GlaxoSmithKline Plc., Allergan Plc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Eli Lily & Company, and Cardinal Health Inc., among others, are some of the major players in the benign prostatic hyperplasia (BPH) prostate treatment market profiled in the full version of the report.

Leading market players are focusing on increasing investment in research and development activities. These participants are keen on offering new treatment options to patients.

More Insights into Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry Report

In its latest report, FMI offers an unbiased analysis of the Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry, providing historical data from 2013 to 2021 and forecast statistics for 2022 to 2028. To understand the global market potential, growth, and scope, the market is segmented based on treatment type (BPH drugs (alpha-blockers, 5-alpha reductase inhibitors, phosphodiesterase-5 (PDE-5) inhibitors, muscarinic receptor antagonist (MRA), combination drug), BPH devices (prostatic stents, suture base implant systems, transurethral RF thermal therapy devices)), distribution channel (institutional sales (hospitals, ambulatory surgical clinics, specialty clinics), retail sales (retail pharmacies, drug stores), online pharmacies), and region.

According to the latest FMI reports, based on segmentation, the institutional sales segment leads the market. This segment accounts for 64.7% of the overall market share owing to the rising demand for minimally invasive surgeries. The retail sales segment accounts for 26.7% while the online pharmacies segment holds 8% of the Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry share.

Based on region, the benign prostatic hyperplasia (BPH) prostate treatment market in the United States will exhibit impressive growth during 2022-2028. The rising geriatric population coupled with increasing cases of BPH propel the target market growth in this country. Growth in research and development activities will further aid the target market growth during the projected period. Besides, India’s benign prostatic hyperplasia (BPH) prostate treatment market, too, will present notable growth. This is due to the popularity of Ayurveda as well as a surge in BPH cases. Thus, these two countries will demonstrate significant growth in the benign prostatic hyperplasia (BPH) prostate treatment market during the forecast period.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/1664

Key Segments of Global Benign Prostatic Hyperplasia (BPH) Prostate Treatment Industry Survey

BPH Prostate Treatment Market by Treatment Type:

  • BPH Drugs
    • Alpha Blockers
    • 5-Alpha Reductase Inhibitors
    • Phosphodiesterase-5 (PDE-5) Inhibitors
    • Muscarinic Receptor Antagonist (MRA)
    • Combination Drug
  • BPH Devices
    • Prostatic Stents
    • Suture Base Implant Systems
    • Transurethral RF Thermal Therapy Devices

BPH Prostate Treatment Market by Distribution Channel:

  • Institutional Sales
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
  • Online Pharmacies

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Gastric Electrical Stimulators Industry is Expected to Grow at a (CAGR) of 6.1% to Reach US$433.8 Million by 2033 | FMI

Global Gastric Electrical Stimulators Industry
Global Gastric Electrical Stimulators Industry

The Global Gastric Electrical Stimulators Industry, medical devices that utilize electrical impulses to treat gastrointestinal diseases, is poised for significant growth over the next decade, according to a recent market analysis. The market is expected to reach a valuation of US$433.8 million by 2033, reflecting a steady Compound Annual Growth Rate (CAGR) of 6.1% from its current value of US$240.6 million in 2023.

Inform Decisions With a Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4044

Two main elements are driving this growth:

  • Technological developments: Patients with chronic stomach disorders like gastroparesis now have a more accurate and maybe more successful therapy option because of the development of high-frequency gastric electrical stimulators. This illness results in delayed stomach emptying, which can induce vomiting, nausea, and malnourishment. For the management of these problems, high-frequency stimulators provide a minimally intrusive option.
  • Management of chronic diseases: There is an increased need for efficient treatment options due to the growing incidence of chronic diseases such as gastroparesis. For patients who have not responded well to conventional drugs or therapy, gastric electrical stimulators offer a dependable and long-term option.

Gastric electrical stimulators are predicted to become more and more in demand due to the growing senior population’s susceptibility to chronic digestive disorders and the growing emphasis on minimally invasive therapies. This pattern, along with continuing technological developments, bodes well for the stomach electrical stimulator industry.

Global Gastric Electrical Stimulators Industry Key Takeaway:

  • The global gastric electrical stimulator market is expected to reach US$433.8 million by 2033, growing at a CAGR of 6.1% from its 2023 valuation of US$240.6 million.
  • Advancements in high-frequency stimulators and their effectiveness in managing chronic conditions like gastroparesis are key growth drivers.

The Dynamic Landscape:

Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interests of potential buyers and create a larger customer base. For instance,

  • IntraPace Inc. was established in 2001 to address an unmet need in weight loss surgery by continuing to develop a gentler solution. The company is focusing on gastric pacing devices that use electrical stimulation to influence gut contractions.

Key Developments in the Global Gastric Electrical Stimulators Industry

  • Medtronic teamed up with Google, a leader in artificial intelligence, to use AI to improve gastric electrical stimulators. This partnership aims to create a cutting-edge stimulator that can adjust to the needs of each patient, potentially revolutionizing the effectiveness and personalization of treatment.
  • The INSPIRE Control wireless stomach electrical stimulator, introduced by IntraPace in 2021, represented a significant advance in patient-centered technology. This wireless technology offers a more practical and patient-friendly alternative by not requiring invasive surgery for installation or removal, potentially changing the face of stomach electrical stimulation therapy.

Unveil Our Research Methods:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-4044

Global Gastric Electrical Stimulators Industry Key Companies Profiled:

  • Medtronic Plc.
  • IntraPace Inc.
  • ReShape Lifesciences Inc.
  • Changzhou Ruishen Medical Equipment Co. Ltd.
  • Chen Tao Medical Equipment
  • Rishena Co. Ltd.
  • Enterra TM

Key Segments of Global Gastric Electrical Stimulators Industry Survey:

By Type:

  • High Frequency
  • Low Frequency

By Application:

By End User:

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East & Africa

Secure Your Market Analysis: Purchase Now to Access: https://www.futuremarketinsights.com/checkout/4044

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Smart Pill Boxes & Bottles Industry is predicted to grow exponentially and reach US$ 388.2 Million by 2033 at a CAGR of 9.3% | FMI

Global Smart Pill Boxes & Bottles Industry
Global Smart Pill Boxes & Bottles Industry

The Global Smart Pill Boxes & Bottles Industry is on track for significant expansion, according to a recent study by Future Market Insights (FMI). Valued at US$144.2 million in 2022, the market is expected to witness a steady rise to US$160.2 million in 2023, marking the beginning of a promising growth trajectory.

FMI’s analysis forecasts an impressive Compound Annual Growth Rate (CAGR) of 9.3% from 2023 to 2033. This upward trend is anticipated to propel the market to a remarkable valuation of US$388.2 million by the end of 2033.

One of the key drivers behind the growth of the smart pill boxes and bottle market is the persistent issue of non-adherence to prescribed medication among adult patients. Studies show that almost 70% of adult patients either discontinue or manipulate their drug therapy, leading to detrimental effects on their health and imposing a significant economic burden on healthcare delivery systems through increased emergency cases and hospitalization.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-1710

Smart pill boxes and bottles are increasingly being perceived as a potential solution to such challenges posed by increased healthcare delivery costs. The significance of medication adherence continues to rise with an increasing prevalence of chronic conditions, propelling demand for the Global Smart Pill Boxes And Bottles Industry.

Dementia and geriatric care remain the key application areas of smart pill boxes and bottles, according to the report. More than 80% of sales is accounted for by aging patients and dementia-afflicted populations. Cancer management is likely to emerge lucrative in terms of applicability in the coming years.

With surging demand for high-quality healthcare delivery, senior care centers, hospitals, long-term care centers, and home care settings are accelerating the adoption of medication dispensers, thereby elevating the revenue growth of the smart pill boxes and bottle market. Some of the leading companies are actively involved in the development of advanced technology medication dispensing devices with zero error risks during medication.

Home care settings maintain the highest consumption share in the smart pill boxes and bottles market which roughly equates to 65% of total sales. Almost a fifth of smart pill boxes and bottles sold are installed at senior care and assisted living centers. FMI’s analysis indicates that long-term care centers are also creating promising

Ask the Expert
https://www.futuremarketinsights.com/reports/brochure/rep-gb-1710

market opportunities for Global Smart Pill Boxes And Bottles Industry manufacturers and distributors.

North America continues to reign supreme owing to early adoption of advanced technology-enabled Global Smart Pill Boxes And Bottles Industry, accounting for more than a third of the global market revenue. The European market for smart pill boxes and bottles also represents a substantial volume share, majorly driven by German patients. South and East Asian regions are briskly developing high-potential markets for manufacturers and distributors of smart pill boxes and bottles, says the report.

The vendor landscape of the smart pill boxes and bottles market remains fairly consolidated and competitive, as Tier 1 manufacturers continue to account for a majority of the share in the market in terms of volume. While the dominance of Koninklijke Philips N.V., PharmRight Corporation & Livi, and AdhereTech prevails in the Global Smart Pill Boxes And Bottles Industry, the report finds that the competition among these players is characterized by product innovation, new launches, and technological advancements.

Global Smart Pill Boxes & Bottles Industry Key Segment

By product type

  • Smart Pill Box
  • Smart Pill Bottles

By indication

By end user

  • Seniors Care & Assisted Living
  • Long-Term Care Centers
  • Home Care Settings

By regions

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/1710

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Anemia Treatment Industry is Expected to Reach US$ 14.9 Billion by 2028 at a Startling 6.9% CAGR | FMI

Global Anemia Treatment Industry
Global Anemia Treatment Industry

The Global Anemia Treatment Industry has surpassed a significant milestone, exceeding a valuation of US$10.0 billion in 2022, according to a recent market analysis. This positive trend is expected to continue, with market analysts forecasting a substantial expansion to reach a projected market worth of US$14.9 billion by 2028. This impressive growth trajectory is fueled by strong sales performance, with a remarkable Compound Annual Growth Rate (CAGR) of 6.9%.

According to a recent report released by Future Market Insights, a significant portion of the demand for Anemia therapy can be attributed to cases arising from one or more chronic medical conditions. This underscores the critical role the industry plays in addressing the healthcare needs of individuals facing anemia associated with various chronic ailments.

The demand for Anemia treatment is chiefly driven by chronic kidney disease (CKD), one of the non-communicable chronic diseases contributing to the demographic shift in emerging regions. Additionally, the increasing popularity of combination therapy is poised to make a substantial impact on the Global Anemia Treatment Industry. The growing utilization of antibiotics, metal chelating agents, erythropoietin-stimulating drugs, and vitamin and iron supplements in combination therapy is recognized as a key driver elevating the prospects of the Anemia treatment Industry in the years to come.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-8966

Vitamin Supplements Gain Significant Traction for Anemia Treatment

A surge in R&D investments is prominently improving the scope of anemia treatment. Moreover, a rising number of pipeline drugs and the promising potential of biosimilars will contribute to the demand for anemia treatment. However, the high price point associated with biologics continues to mask their superior treatment efficacy over conventional medications.

More than 75% of anemia treatment Industry revenue is accounted by medications, of which, ESAs (erythropoietin stimulating agents) remain bestselling. Blood transfusion is also cited as an important type of anemia treatment, contributing to the market growth. However, the demand for the former is poised for a robust double-digit yearly growth in 2021 and ahead.

The lucrative emergence of ESAs and soaring consumption of other biosimilar medications are likely to introduce new investment opportunities in the Global Anemia Treatment Industry. The extensive availability, accessibility, and economic price point of biosimilar drugs are strongly backed by an increasing number of FDA approvals. This according to FMI will significantly contribute to the improvement of CKD, thereby bolstering the revenue of the anemia treatment Industry. FDA recently issued approval to a biosimilar drug by Pfizer for use in anemia treatment – Retacrit (epoetin alfa-epoxy).

Over 55% of dietary supplements consumed as a part of anemia treatment are vitamin supplements. An increasing number of iron-deficient patients will Unveil

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-8966

reportedly result in rapid demand growth for iron supplements in years to come, posing strong competition to those vitamin supplements in the Global Anemia Treatment Industry. Currently, almost 60% of the medications and dietary supplements for anemia treatment are available at institutional pharmacies. The report also points to a gradually expanding share of retail pharmacies shortly.

North American patients raise just under a third of the global demand for anemia treatment, whereas more than a third of the total demand is accounted for collectively by East and South Asia. Europe is also cited as one of the key regional markets for anemia treatment providers.

Product-based Business Models Emerge as a Key Competitive Strategy

The consistent quest for therapeutically effective ESAs, dietary supplements, antibiotics, and other biologics to be used in anemia treatment continues to create attractive avenues in the R&D realm. Leading drug manufacturers are investing efforts in launching novel products and upgrading their existing consumable product portfolios. Amgen’s epoetin alpha has been a breakthrough product since its launch in the CKD treatment landscape and growing adoption continues to benefit the company.

Besides augmenting R&D investments, prominent players in the anemia treatment Industry are also focusing on strategic agreements and partnerships – further paving the way for the development of anemia treatment drugs. The emergence of partnership-based models in the competitive landscape of the anemia treatment market is likely to reshape the R&D structure in the anemia treatment Industry. The report prompts major investment opportunities arising in open collaboration strategies. Several drug manufacturers are also opting for partnerships with regional distribution leaders to form effective product-based distribution channels, particularly targeting developing regional markets.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/8966

Global Anemia Treatment Industry by Category

By Treatment:

  • Medications
  • Dietary Supplements

By Disease:

  • Normocytic anemia
  • Microcytic anemia
  • Macrocytic anemia

By Distribution Channel:

  • Institutional Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies

Global Anemia Treatment Industry Key Companies Profiled:

  1. Amgen Inc.
  2. Hoffmann-La Roche Ltd.
  3. Novartis AG
  4. Pfizer Inc.
  5. Janssen Pharmaceuticals, Inc.
  6. Teva Pharmaceutical Industries Ltd.
  7. AMAG Pharmaceuticals
  8. Rockwell Medical
  9. Akebia Therapeutics
  10. Vifor Pharma Management Ltd.

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Dental X-Ray Systems Industry is expected to reach US$ 2.73 Billion by 2030, With an impressive 6.4% CAGR | FMI

Global Dental X-Ray Systems Industry
Global Dental X-Ray Systems Industry

The Global Dental X-Ray Systems Industry is experiencing a surge in growth, according to a recent analysis by Future Market Insights (FMI). Currently valued at approximately US$1.66 billion, the market is projected to maintain a robust Compound Annual Growth Rate (CAGR) of 6.4% over the next eight years, reaching an impressive US$2.73 billion by 2030.

The escalating demand for advanced diagnostic tools is a driving force behind this remarkable growth. The surge in demand is primarily fueled by an increasing incidence of acute diseases, such as cancer, emphasizing the need for effective diagnostics and treatment options. Early detection of diseases is crucial for improving the probability of survival, and dental X-ray systems are emerging as promising diagnostic and treatment tools to meet this pressing need.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-8960

The rising geriatric population and their edentulous issues directly open lucrative opportunities for the dental X-ray systems market. Moreover, healthcare facilities utilized by the elderly population are subsidized by the government, which in turn, has boosted the usage of dental X-ray systems. A report published by Future Market Insights (FMI) opines that the global dental X-ray systems market will grow at a striking CAGR of over 6% by the end of 2026.

With the increasing comfort provided by portable intraoral X-ray systems, the traditionally used floor-mounted dental X-ray systems are gradually becoming obsolete. When weighted based on cost, dental X-ray systems provide far better affordability to dental clinics and hospitals as compared to cone-beam computed tomography (CBCT) systems, which is why the sales prospects of the former are better.

Challenges To the Global Dental X-Ray Systems Industry: Reduction in Reimbursement

A notable reduction in the primary healthcare facilities for many diseases including oral health will affect the capacity and the resources adversely. Newly formed legislation will enforce reduced reimbursement regulations on the MPFS (Medicare Physician FEE Schedule) and HOPPS (Hospital Outpatient Prospective Payment System), which is expected to cause a drop in the growth of the dental X-ray systems market.

Technological Advancements to Lend Ample Growth Opportunities to the Global Dental X-Ray Systems Industry

Innovations and advancements brought about in the medical imaging vicinity especially, dental X-ray systems have intensified the growth prospects of the dental X-ray systems market. Owing to the progress made by the healthcare industry, there has been a consistent need for the precise diagnosis of diseases, which has been fulfilled by dental X-ray systems. Given the multifold applications of these systems, the Global Dental X-Ray Systems Industry is projected to grow exponentially.

Access the Complete Report Methodology Now
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-8960

North America to Maintain a Strong Hold on the Global Dental X-Ray Systems Industry

The study on the dental X-ray systems market provides a detailed analysis based on several factors affecting the market growth. The key geographies assessed in this study include China, APEC, Europe, Latin America, North America, and the Middle East and Africa (MEA). Depending on the market size, North America leads the dental X-ray systems market, attributed to its advanced healthcare facilities and excellent spending capacity. As a subsequence, the regional dental X-ray systems market is expected to bear positive results for the global dental X-ray systems market.

Following the footsteps of North America, Europe is the second most dominating region influencing the growth of the dental X-ray systems market. In addition to this, Asia Pacific is equally estimated to contribute to the growing market size during 2018 – 2026.

Collaboration and Mergers to Trigger the Growth of the Global Dental X-Ray Systems Industry

The report on the dental X-ray systems market includes a comprehensive analysis of the companies devising innovative solutions in the market. The leading players incorporated in the report are FONA, J. MORITA CORP., Danaher Corporation, PLANMECA OY, Prexion Corporation, Carestream Dental, LLC, Owandy Radiology, Vatech Co. Ltd., The Yoshida Dental Mfg. Co. Ltd., Dentsply Sirona, LED Medical Diagnostics Inc., Cefla S.C., and Air Techniques, Inc., among others.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/8960

Key Segments Of Dental X-Ray Systems Industry Survey

Global Dental X-Ray Systems Industry by Product:

  • Cephalometric Projections Systems
  • Portable Intraoral X-ray Systems
  • Panoramic X-ray Systems
  • Intraoral X-ray Systems Mounted on the Floor

Global Dental X-Ray Systems Industry by End User:

Global Dental X-Ray Systems Industry by Region:

  • North America Dental X-ray Systems Market
  • Latin America Dental X-ray Systems Market
  • Europe Dental X-ray Systems Market
  • East Asia Dental X-ray Systems Market
  • South Asia & Pacific Dental X-ray Systems Market
  • Middle East & Africa (MEA) Dental X-ray Systems Market

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Retinal Biologics Industry is expected to reach an impressive valuation of US$41.92 Billion by 2028, driven by a resilient 11.1 CAGR | FMI

Global Retinal Biologics Industry
Global Retinal Biologics Industry

The Global Retinal Biologics Industry is experiencing a surge in growth, according to a recent market analysis by Future Market Insights (FMI). Currently valued at an impressive US$22.25 billion in 2022, the market is expected to continue its upward trajectory, reaching a staggering US$41.92 billion by 2028. This translates to a robust Compound Annual Growth Rate (CAGR) of 11.1% over the forecast period.

The remarkable expansion of the Global Retinal Biologics sector is fueled by advancements in technology, innovative research, and a growing demand for cutting-edge treatments. As the industry continues to evolve, it presents unprecedented opportunities for stakeholders, investors, and healthcare professionals alike.

Key Global Retinal Biologics Industry Insights:

  1. Rising Prevalence of Diabetes-related Eye Disorders and Age-related Macular Degeneration (AMD) The prevalence of diabetes-related eye disorders and age-related macular degeneration is on the rise, underscoring the growing need for innovative solutions within the Retinal Biologics Industry.
  2. Substantial Investment in R&D for Biologics in Retinal Disorders The industry is witnessing a significant influx of research and development resources, aimed at advancing biologics for both infectious and non-infectious retinal disorders. This investment underscores the commitment to addressing unmet medical needs.
  3. Emergence of Specific Biologic Molecules as Therapeutic Targets Specific biologic molecules are gaining prominence as highly promising therapeutic targets, offering new hope for patients with retinal conditions.
  4. Gene Therapy as a Solution for Monogenic Retinal Illnesses With a growing number of monogenic retinal illnesses, gene therapy is emerging as a pivotal component of the Retinal Biologics Market, presenting innovative solutions for these challenging conditions.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-8663

Retinal Biologics Distribution in Specialty Clinics and Hospitals Prominent

Retinal Biologics manufacturers offer their goods through institutional and retail distribution channels. According to the FMI report, institutional sales in the Retinal Biologics Industry, where Retinal Biologics are supplied in speciality clinics and hospitals, will generate higher revenues. In 2018, hospital sales accounted for more than 35% of market revenue.

According to the report, retail sales of Retinal Biologics will generate comparable revenues to hospital sales and will expand at an 11.9% annual rate in 2019. Retail distribution takes place through retail pharmacies and mail-order pharmacies, with retail pharmacies generating more money than their counterparts in the future years.

Penetration in North America Higher, APEJ’s Attractiveness to Increase

North America continues to be the market leader in Retinal Biologics revenue. According to FMI estimates, North America accounted for more than 46% of global Retinal Biologics Industry revenues in 2018. Revenues in North America are predicted to expand 10.4% year on year in 2019 due to an increase in the prevalence of retinal illnesses, continuous growth in the healthcare infrastructure, and a favourable reimbursement scenario.

Europe accounted for about one-fourth of the Retinal Biologics market, with Western European countries such as Germany, the United Kingdom, France, Italy, and Spain accounting for the majority of demand penetration. The APEJ Retinal Biologics Industry is predicted to grow at an 11% annual rate in 2019, with China and India remaining the most lucrative areas.

Ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-8663

Retinal Biologics Find Prominent Use in Macular Degeneration Treatment

The study opines that over 35% of the Retinal Biologics revenues were consolidated in the treatment of macular degeneration. Highest revenue growth of 12.3% is also expected in macular degeneration as compared to other indications where Retinal Biologics are used in 2019.

Macular degeneration (MD) remains the leading cause of vision loss wherein it affects over 10 million Americans, the prevalence is higher than the combined incidences of cataracts and glaucoma, as per the American Macular Degeneration Foundation (AMDF). As macular degeneration mainly affects people of age 50 years or more, with the ageing population, the prevalence of MD continues to rise despite improved treatment options.

Key Players Covered In The Global Retinal Biologics Industry:

  • Spark Therapeutics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Regeneron Pharmaceuticals, Inc.
  • AbbVie Inc.
  • Amgen Inc.
  • Novartis Pharma AG
  • MeiraGTx Limited
  • Oxurion NV
  • Santen Pharmaceutical Co., Ltd.
  • Bayer AG
  • Bausch Health Companies Inc.
  • Merck & Co., Inc.

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/8663

Key Segments of Global  Retinal Biologics Industry Survey

Global Retinal Biologics Industry by Drug Class:

  • VEGF-A Antagonists
  • TNF-α Inhibitors

Global Retinal Biologics Industry by Indication:

Global Retinal Biologics Industry by Distribution Channel:

  • Institutional Sales
  • Retail Pharmacies
  • Mail Order Pharmacies
  • Retail Sales

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube